Effects of small interfering RNA inhibit Class I phosphoinositide 3-kinase on human gastric cancer cells

被引:6
|
作者
Zhu, Bao-Song [1 ]
Yu, Li-Yan [1 ]
Zhao, Kui [1 ]
Wu, Yong-You [1 ]
Cheng, Xiao-Li [2 ]
Wu, Yong [1 ]
Zhong, Feng-Yun [1 ]
Gong, Wei [1 ]
Chen, Qiang [1 ]
Xing, Chun-Gen [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou 215004, Jiangsu, Peoples R China
[2] Shandong Univ, Dept Gastroenterol, Qianfoshan Hosp, Jinan 250014, Shandong, Peoples R China
关键词
Gastric cancer cells; Class I phosphoinositide 3-kinase; RNA interference; Apoptosis; Autophagy; ACTIVATED MAMMALIAN TARGET; CISPLATIN RESISTANCE; PI3K/AKT PATHWAY; OVARIAN-CANCER; DNA-DAMAGE; AUTOPHAGY; RAPAMYCIN; BECLIN-1; DEATH; GENE;
D O I
10.3748/wjg.v19.i11.1760
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the effects of small interfering RNA (siRNA)-mediated inhibition of Class. phosphoinositide 3-kinase (Class I PI3K) signal transduction on the proliferation, apoptosis, and autophagy of gastric cancer SGC7901 and MGC803 cells. METHODS: We constructed the recombinant replication adenovirus PI3K(I)-RNA interference (RNAi)-green fluorescent protein (GFP) and control adenovirus NC-RNAi-GFP, and infected it into human gastric cancer cells. MTT assay was used to determine the growth rate of the gastric cancer cells. Activation of autophagy was monitored with monodansylcadaverine (MDC) staining after adenovirus PI3K(I)-RNAi-GFP and control adenovirus NC-RNAi-GFP treatment. Immunofluorescence staining was used to detect the expression of microtubule-associated protein 1 light chain 3 (LC3). Mitochondrial membrane potential was measured using the fluorescent probe JC-1. The expression of autophagy was monitored with MDC, LC3 staining, and transmission electron microscopy. Western blotting was used to detect p53, Beclin-1, Bcl-2, and LC3 protein expression in the culture supernatant. RESULTS: The viability of gastric cancer cells was inhibited after siRNA targeting to the Class. PI3K blocked Class. PI3K signal pathway. MTT assays revealed that, after SGC7901 cancer cells were treated with adenovirus PI3K(I)-RNAi-GFP, the rate of inhibition reached 27.48% +/- 2.71% at 24 h, 41.92% +/- 2.02% at 48 h, and 50.85% +/- 0.91% at 72 h. After MGC803 cancer cells were treated with adenovirus PI3K(I)-RNAi-GFP, the rate of inhibition reached 24.39% +/- 0.93% at 24 h, 47.00% +/- 0.87% at 48 h, and 70.30% similar to 0.86% at 72 h (P < 0.05 compared to control group). It was determined that when 50 MOI, the transfection efficiency was 95% +/- 2.4%. Adenovirus PI3K(I)RNAi-GFP (50 MOI) induced mitochondrial dysfunction and activated cell apoptosis in SGC7901 cells, and the results described here prove that RNAi of Class. PI3K induced apoptosis in SGC7901 cells. The results showed that adenovirus PI3K(I)-RNAi-GFP transfection induced punctate distribution of LC3 immunoreactivity, indicating increased formation of autophagosomes. The results showed that the basal level of Beclin-1 and LC3 protein in SGC7901 cells was low. After incubating with adenovirus PI3K(I)-RNAi-GFP (50 MOI), Beclin-1, LC3, and p53 protein expression was significantly increased from 24 to 72 h. We also found that Bcl-2 protein expression down-regulated with the treatment of adenovirus PI3K(I)-RNAi-GFP (50 MOI). A number of isolated membranes, possibly derived from ribosome-free endoplasmic reticulum, were seen. These isolated membranes were elongated and curved to engulf a cytoplasmic fraction and organelles. We used transmission electron microscopy to identify ultrastructural changes in SGC7901 cells after adenovirus PI3K(I)RNAi-GFP (50 MOI) treatment. Control cells showed a round shape and contained normal-looking organelles, nucleus, and chromatin, while adenovirus PI3K(I)-RNAi-GFP (50 MOI)-treated cells exhibited the typical signs of autophagy. CONCLUSION: After the Class. PI3K signaling pathway has been blocked by siRNA, the proliferation of cells was inhibited and the apoptosis of gastric cancer cells was enhanced. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:1760 / 1769
页数:10
相关论文
共 50 条
  • [1] Effects of small interfering RNA inhibit Class Ⅰ phosphoinositide 3-kinase on human gastric cancer cells
    Bao-Song Zhu
    Li-Yan Yu
    Kui Zhao
    Yong-You Wu
    Xiao-Li Cheng
    Yong Wu
    Feng-Yun Zhong
    Wei Gong
    Qiang Chen
    Chun-Gen Xing
    World Journal of Gastroenterology, 2013, (11) : 1760 - 1769
  • [2] Effects of 5-fluorouracil and class III phosphoinositide 3-kinase small interfering RNA combination therapy on SGC7901 human gastric cancer cells
    Zhu, Bao-Song
    Sun, Jia-Lei
    Gong, Wei
    Zhang, Xing-Ding
    Wu, Yong-You
    Xing, Chun-Gen
    MOLECULAR MEDICINE REPORTS, 2015, 11 (03) : 1891 - 1898
  • [3] Shedding light on class I phosphoinositide 3-kinase activity in endothelium
    Diacovo, Thomas G.
    BLOOD, 2008, 111 (09) : 4827 - 4828
  • [4] Differential activation of class I phosphoinositide 3-kinase by growth factors
    Ghosh, Dibbendu
    Liu, Shu-Lin
    Cho, Wonhaw
    FASEB JOURNAL, 2017, 31
  • [5] Modulation of acid secretion by phosphoinositide 3-kinase in gastric parietal cells
    Mettler, Shelley Elizabeth
    Ghayouri, Sara
    Forte, John G.
    FASEB JOURNAL, 2007, 21 (06): : A1210 - A1211
  • [6] Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer
    Edling, Charlotte E.
    Selvaggi, Federico
    Buus, Richard
    Maffucci, Tania
    Di Sebastiano, Pierluigi
    Friess, Helmut
    Innocenti, Paolo
    Kocher, Hemant M.
    Falasca, Marco
    CLINICAL CANCER RESEARCH, 2010, 16 (20) : 4928 - 4937
  • [7] Small-molecule agonists of SHEP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells
    Ong, Christopher J.
    Ming-Lum, Andrew
    Nodwell, Matt
    Ghanipour, Ali
    Yang, Lu
    Williams, David E.
    Kim, Joseph
    Demirjian, Loutfig
    Qasimi, Pooran
    Ruschmann, Jens
    Cao, Li-Ping
    Ma, Kewei
    Chung, Stephen W.
    Duronio, Vincent
    Andersen, Raymond J.
    Krystal, Gerald
    Mui, Alice L. -F.
    BLOOD, 2007, 110 (06) : 1942 - 1949
  • [8] Analysis of class I phosphoinositide 3-kinase autophosphorylation sites by mass spectrometry
    Czupalla, C
    Nürnberg, B
    Krause, E
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (07) : 690 - 696
  • [9] Identification of AMG 511 as a selective class I phosphoinositide 3-kinase inhibitor
    Wurz, Ryan P.
    Andrews, Kristin L.
    Bo, Yunxin Y.
    Booker, Shon K.
    Caenepeel, Sean
    Cee, Victor J.
    Noel, D'Angelo D.
    Freeman, Daniel J.
    Herberich, Bradley J.
    Hong, Fang-Tsao
    Jackson, Claire L. M.
    Jiang, Jian
    Lanman, Brian A.
    Liu, Longbin
    McCarter, John D.
    Mullady, Erin L.
    Nishimura, Nobuko
    Pettus, Liping H.
    Reed, Anthony B.
    San Miguel, Tisha
    Smith, Adrian L.
    Stec, Markian M.
    Tadesse, Seifu
    Tasker, Andrew S.
    Aidasani, Divesh
    Zhu, Xiaochun
    Subramanian, Raju
    Tamayo, Nuria A.
    Wang, Ling
    Whittington, Douglas A.
    Wu, Bin
    Wu, Tian
    Yang, Kevin
    Zalameda, Leeanne
    Zhang, Nancy
    Hughes, Paul E.
    Norman, Mark H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [10] Targeting phosphoinositide 3-kinase signalling in small cell lung cancer
    Wojtalla, A.
    Fischer, B.
    Mauri, F. A.
    Sobek, J.
    Zoller, S.
    Seckl, M. J.
    Arcaro, A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 92 - 92